None of the four cough syrups — Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup — being linked to the death of 66 children in the Gambia is available for sale in India, said the All India Organisation of Chemists and Distributors (AIOCD).
The group said it had assured the Drug Controller of India that in case these drugs were in the Indian market, their supply would be halted immediately.
The World Health Organization (WHO) issued a warning on Wednesday about these drugs manufactured by the Haryana-based Maiden Pharmaceuticals following which the Indian Government initiated a probe and the results are expected later this week. The Indian Government will also look at where else these medicines have been exported and the importing countries typically test such products before allowing their use.
